LUCA Science Announces Oral Presentation at the American Heart Society (AHA) 2023 Annual Meeting and Academic Conferences on Mitochondria

Notice of Establishment of Board of Statutory Auditors

LUCA Science Announces Oral Presentation at the 75th Annual Congress of the Japan Society of Obstetrics and Gynecology 2023 (JSOG 2023)

LUCA Science Was Selected in the Japanese Startup Support Program “J-Startup” by the Ministry of Economy, Trade and Industry of Japan

LUCA Science Announces Oral Presentation at the 21st Japanese Society of Mitochondrial Research and Medicine (J-mit) Annual Meeting

LUCA Science Was Selected as Top 10 Japanese Emerging Deep Tech Companies by Forbes JAPAN

LUCA Science Announces Oral Presentation at the American Society of Hematology (ASH) 2022 Annual Meeting

LUCA Science Announces Poster Presentation at Cell Symposia: Multifaceted Mitochondria

LUCA Science Announces Oral Presentations at the World Mitochondria Society (WMS) 2022 Annual Meeting

LUCA Science announced the closing of a ¥3.86 Billion ($30.3 Million) Series B financing.

LUCA Science has opened its own CMC research laboratory in Tokyo, and is pleased to announce that Tomoyuki Inoue has been appointed as Head of CMC.

LUCA Science has announced the expansion of its international operations, with the establishment of a new wholly-owned subsidiary company in the UK.

LUCA Science applied to the 5th call of “Medical Research and Development Innovation Infrastructure Creation Project (CiCLE)” proposals supported by Japan Agency for Medical Research and Development.

LUCA Science Inc. is honoured to announce that Prof. Joanna Poulton, at the University of Oxford, has agreed to become a scientific advisor.

LUCA Science announced that it will collaborate With Division of Cardiology, Nagoya University on the Development of Mitochondrial Therapy for Myocardial Infarction.

LUCA Science Inc. announces that Dr. Hisashi Ohta has been appointed as Head of Research & LUCA Laboratory at our Hokkaido university campus.